Pedro González-Naranjo

Cannabinoid agonists showing BuChE inhibition as potential therapeutic agents for Alzheimer's disease

Pedro González-Naranjo, Natalia Pérez-Macías, Nuria E. Campillo et al. · European Journal of Medicinal Chemistry · 2013 · 50 citations · Full text

Life Sciences, Neuroscience, Pharmacology +10

Cannabinoid derivatives exert a potent anti-myeloma activity both<i>in vitro</i>and<i>in vivo</i>

María Victoria Barbado, Mayte Medrano, Teresa Caballero‐Velázquez et al. · International Journal of Cancer · 2016 · 36 citations · Full text

Medicine, Oncology, Pharmacology +17

Indazolylketones as new multitarget cannabinoid drugs

Pedro González-Naranjo, Natalia Pérez-Macías, Concepción Pérez et al. · European Journal of Medicinal Chemistry · 2019 · 20 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11

Multitarget Cannabinoids as Novel Strategy for Alzheimer Disease

Pedro González-Naranjo, Nuria E. Campillo, Concepción Pérez et al. · Current Alzheimer Research · 2013 · 17 citations

Pharmacy, Medicinal Chemistry, Pharmacology +16

Multitarget drugs as potential therapeutic agents for alzheimer’s disease. A new family of 5-substituted indazole derivatives as cholinergic and BACE1 inhibitors

Pedro González-Naranjo, Marina González‐Sánchez, Adrián Gironda-Martínez et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2022 · 15 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17